Ticker Details
Rockwell Medical, Inc. (DE) Common Stock Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.
IPO Date:	February 1, 1998
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$32.65M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 3.32%
Avg Daily Range (30 D):	$0.22 | 3.17%
Avg Daily Range (90 D):	$0.10 | 3.06%

Institutional Daily Volume
Avg Daily Volume:	.38M
Avg Daily Volume (30 D):	.02M
Avg Daily Volume (90 D):	.18M

Trade Size
Avg Trade Size (Sh.):	267
Avg Trade Size (Sh.) (30 D):	107
Avg Trade Size (Sh.) (90 D):	339

Institutional Trades
Total Institutional Trades:	185
Avg Institutional Trade:	$1.17M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.46M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	3.07K

News

Aug 14, 2025 @ 10:21 AM Rockwell Medical Tops Q2 EPS View Source: Jesterai

Oct 9, 2024 @ 8:12 PM DaVita Stock Gains 47.3% Year to Date: What's Behi... Source: Zacks, Benzinga Contributor

May 14, 2024 @ 11:15 AM Rockwell Medical (RMTI) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research

Mar 26, 2024 @ 10:15 PM Rockwell Medical (RMTI) Increases Despite Market S... Source: Zacks Equity Research

Mar 21, 2024 @ 11:10 AM Rockwell Medical (RMTI) Q4 Earnings and Revenues B... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.8	$-.34	$-.04
Diluted EPS	$-.8	$-.7	$-.04
Revenue	$69.39M	$17.78M	$17.34M
Gross Profit	$12.29M	$3.24M	$2.9M
Net Income / Loss	$-5.08M	$-1.17M	$-1.61M
Operating Income / Loss	$-4.52M	$-1.06M	$-1.48M
Cost of Revenue	$57.1M	$14.54M	$14.44M
Net Cash Flow	$-1.96M	$.91M	$-1.1M
PE Ratio

Splits
Jul 01, 2026	1:10
May 13, 2022	1:11